Europa-Parlamentet lancerede en revideret EU-lægemiddelpakke i første kvartal af 2023. Blandt de konstaterede svagheder er opdelingen af EU's forskning og udvikling inden for sundhedsområdet, manglende gennemsigtighed og forskelle mellem offentlige investeringer og kliniske resultater. En mulig løsning er at oprette en storstilet biomedicinsk infrastruktur i EU samt en række målrettede strategier, der skal forbedre koordinationen af sundhedsforskning i EU, og omprioritere områder inden for sundhedspleje med uopfyldte terapeutiske behov.

En ny EU-lægemiddelstrategi - Dansk

EP Plenary session - Recommendation on smoke and aerosol-free environments

ENVI Workshop on ' Complementary and alternative therapies for patients today and tomorrow '

Geography matters - Inequalities in Access to Stroke Care and Innovation in Europe

Meeting about lower sugar manufactured and prepared foods - Sugar wise

MEPs outline proposals to improve the protection of EU citizens against exposure to second-hand smoke and aerosols, including from electronic cigarettes. In Europe’s Beating Cancer Plan, the Commission has previously announced its intention to update the current Council Recommendation on smoke-free environments, which dates back to 20019. A revision was needed to extend its scope to certain emerging products, such as electronic cigarettes and heated tobacco, due to the rapid market growth and appeal of such products in recent years, especially among young people. The Commission recommends EU countries reduce the risk of second-hand exposure by banning the use of all tobacco products in certain outdoor spaces, such as public playgrounds and amusement parks, areas related to restaurants/cafés, public transportation, healthcare and education establishments, as well as workplaces.

Smoke and aerosol-free environments: Closing statements

Smoke and aerosol-free environments: MEPs debate

Smoke and aerosol-free environments: Opening statements

Health is essential for a fulfilling life—and a strong health sector is vital for both our well-being and our economy. In the EU, the health sector contributes 11% of GDP and provides one in ten jobs. But did you know that Europe is falling behind in health innovation compared to global competitors? Investing in EU-wide health innovation could unlock ground-breaking treatments, boost our competitiveness, and create new economic opportunities. By pooling resources and sharing risks, we can achieve more together—transforming lives while fostering growth. Discover more in our EPRS study on the Cost of Non-Europe in Health Policy

Unlocking health innovation

In the EU, 1.8 million people under 75 died in 2021. 72 % of these deaths could have been avoided: 3 in 10 with timely, effective medical treatment; 7 in 10 with better preventive measures. In that same year, the leading causes of avoidable deaths were COVID-19, ischaemic heart diseases and lung cancer. These three diseases mostly affected men. The death rate from avoidable diseases also varies widely across the EU. Learn more about how the EU can turn the tide on preventable losses and create a healthier EU for everyone

Turning the tide on avoidable deaths in the EU

With the COVID-19 pandemic, war returning to Europe and the accompanying energy crisis, and a worsening economic outlook, all on top of a climate crisis, today's young Europeans are growing up in a volatile and difficult world. Concerns about economic prosperity, increasing competition for jobs, rising inflation and property prices make it difficult for young people to get ahead in life, to afford housing, to attain economic stability and to achieve a sense of satisfaction in society. Furthermore, underpinning many of these changes is digitalisation, which is also changing the way we socialise, work and live, with emerging consequences for mental health. Dive deeper:

Mental health among young European

Air pollution continues to be the number one environmental cause of early death in the EU with around 300 000 premature deaths per year, with the most harmful being particulate matter (PM2.5, PM10), NO2 (nitrogen dioxide), SO2 (sulphur dioxide) and O3 (ozone). The draft report by Javi LOPEZ (S&D, ES) on ambient air quality and cleaner air for Europe sets stricter 2030 limits relative to the Commission proposal to ensure that air quality in the EU is not harmful to human health, natural ecosystems and biodiversity. MEPs also want to increase the number of air quality sampling points and harmonise currently-fragmented air quality indices to provide better information to citizens. This infoclip illustrates air pollution, an air quality sampling station and tests for pulmonary capacity and airborne allergies.

Infoclip: Ambient air quality

The COVI Committee (Special Committee on the COVID-19 pandemic) votes on its final report, adopted by 23 votes in favour, 13 against and one abstention. Extracts from the vote and statements by Dolors MONTSERRAT (EPP,ES), Rapporteur and by Kathleen VAN BREMPT (S&D,BE), COVI Chair. The report which concludes the year and three months a half long intensive work of the Committee on collecting the evidence and lessons learned from the COVID-19 pandemic and the impact it had on citizens and their fundamental rights, the businesses, the health sector and international community.

COVID-19 pandemic: lessons learned and recommendations for the future: extracts from the vote (12/06) and statements by Dolors MONTSERRAT (EPP, ES), Rapporteur and by Kathleen VAN BREMPT (S&D, BE), COVI Chair

From 2020 to 2022, the European Union has faced a public health threat with the COVID-19 pandemic. On 10 March 2022, the European Parliament established a new special committee on the COVID-19 pandemic, composed of 38 members. After more than a year of work, the final report is voted and presents its recommendations for the future, based on the lesson learned. This clip illustrates two years of pandemic through footages of lockdowns, testings, masks distributions, vaccinations, digital certificates but also comes back on the work of the COVI Committee with extracts of past meetings.

Memoclip: COVID-19 pandemic - lessons learned and recommendations for the future

The new subcommittee on public health (SANT) elected MEP Bartosz Arłukowicz as Chair, as well as the four Vice-Chairs, at its constitutive meeting, Chair: Bartosz ARŁUKOWICZ (EPP, PL), First Vice-Chair: Tudor CIUHODARU (S&D, RO), Second Vice-Chair: Irena JOVEVA (Renew Europe, SI), Third Vice-Chair: Tilly METZ (Greens/EFA), Fourth Vice-Chair: - Joanna KOPCIŃSKA (ECR, PL). According to its approved mandate, the subcommittee will deal with pharmaceutical and cosmetic products, the health aspects of bioterrorism, the European Medicines Agency, and the European Centre for Disease Prevention and Control.

New Subcommittee on Public Health (SANT): extracts from the constitutive meeting, election of the Chair and statement by Bartosz ARŁUKOWICZ (EPP, PL) new elected Chair

The European Union is currently facing supply shortages for many common medications and antibiotics. Painkillers and drugs against fever are for exemple in short supply in pharmacies, forcing them to start their own production. MEPs debate in plenary. Extracts.

Surge of respiratory infections and the shortage of medication in Europe: extracts from the debate

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Exchange of views with CEOs of the pharmaceutical industry on COVID 19 (Corona) vaccine production and delivery. Closing remarks by Thierry BRETON, European Commissioner for Internal Market.

Joint ENVI - ITRE Hearing Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Statement by Thierry BRETON, European Commissioner for Internal Market

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Session 2- Presentations by Paul STOFFELS, Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, Angela HWANG, President Global Biopharma, Pfizer Group, accompanied by Germain MORIN, VP Vaccines Supply Chain, Thomas TRIOMPHE, Executive Vice-President, Head of Sanofi Pasteur, Suerie MOON, Co-Director, Global Health Centre, Graduate Institute of International and Development Studies, Geneva.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Session 2 - CEOs of the pharmaceutical industry

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Q&A with CEOs of the pharmaceutical industry Paul STOFFELS, Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, Angela HWANG, President Global Biopharma, Pfizer Group, accompanied by Germain MORIN, VP Vaccines Supply Chain, Thomas TRIOMPHE, Executive Vice-President, Head of Sanofi Pasteur ,Suerie MOON, Co-Director, Global Health Centre, Graduate Institute of International and Development Studies, Geneva.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Q&A with ENVI and ITRE Members and CEOs of the pharmaceutical industry

This infoclip illustrates the range of rules aimed at stopping the spread of Covid-19 in Prague, Czech Republic (social distancing, wearing the mask compulsory in different situation, signage, non-essential shops, restaurants and bars temporarily closed...) and the impact on the economy and different sectors such as tourism, culture or catering. New restrictions are in place from Oct. 22.

Infoclip: Illustration of the lockdown situation in Prague, Czech Republic

This infoclip illustrates exterior and interior views of the the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden and a person consulting a map the situation updates on COVID-19. Based on data provided by the Member States, this European Agency publish a map of EU Member States which show the risk levels across the regions.

Infoclip: European Centre for Disease Prevention and Control (ECDC) – Maps on COVID-19 situation

This infoclip shows fashion design students sew reusable surgical gowns in a school in Brussels during the Covid-19 (coronavirus) outbreak. First, they cut the fabrics from a pattern and then they sew the different parts of the gown.

Infoclip: Covid-19 - Health and Medical equipment: production of medical gowns

This video shows an outdoor Covid-19 screening center set up in the city of Lingolsheim, France, during the Coronavirus outbreak. Citizens queue to be tested by doctors and nurses. The serological test is carried out by means of a blood test. The PCR (polymerase chain reaction) test is carried out using an RNA sample. Deep nasal cells are removed using a swab (a kind of long cotton swab) which is inserted into the nostrils. The samples are then analyzed in the laboratory.

23 resultater